We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ADMA market cap is 1.41B. The company's latest EPS is USD -0.1237 and P/E is -50.12.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 41.09M | 49.98M | 56.91M | 60.12M | 67.27M |
| Operating Income | -9.32M | -6.06M | -813k | -474k | 8.69M |
| Net Income | -14.9M | -12.23M | -6.79M | -6.37M | 2.57M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 29.35M | 42.22M | 80.94M | 154.08M | 258.22M |
| Operating Income | -41.43M | -64.91M | -58.37M | -39.37M | 21.63M |
| Net Income | -48.28M | -75.75M | -71.65M | -65.9M | -28.24M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 300.56M | 348.46M | 340.79M | 343.03M | 349M |
| Total Liabilities | 200.17M | 196.49M | 195.13M | 196.27M | 197.56M |
| Total Equity | 100.39M | 151.97M | 145.66M | 146.76M | 151.44M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 127.09M | 207.67M | 276.25M | 348.46M | 329.18M |
| Total Liabilities | 100.9M | 119.42M | 135.08M | 196.49M | 193.98M |
| Total Equity | 26.19M | 88.25M | 141.17M | 151.97M | 135.21M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -52.13M | -59.51M | -14.72M | -20.78M | -8.8M |
| Investing | -10.16M | -13.91M | -1.95M | -2.82M | -3.57M |
| Financing | 46.11M | 108.85M | -651k | -409k | 5k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -76.19M | -102M | -112.37M | -59.51M | 8.8M |
| Investing | -3.81M | -12.73M | -13.51M | -13.91M | -4.98M |
| Financing | 80M | 143.9M | 121.05M | 108.85M | -38.99M |
| Market Cap | 1.41B |
| Price to Earnings Ratio | -50.12 |
| Price to Sales Ratio | 5.48 |
| Price to Cash Ratio | 27.56 |
| Price to Book Ratio | 10.47 |
| Dividend Yield | - |
| Shares Outstanding | 228.22M |
| Average Volume (1 week) | 1.65M |
| Average Volume (1 Month) | 2.3M |
| 52 Week Change | 84.18% |
| 52 Week High | 6.76 |
| 52 Week Low | 3.06 |
| Spread (Intraday) | 0.14 (2.26%) |
| Company Name | Adma Biologics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.admabiologics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
